No Data
No Data
Earnings Call Summary | Organogenesis(ORGO.US) Q4 2023 Earnings Conference
The following is a summary of the Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript:Financial Performance:Organogenesis reported Q4 net revenue of $99.7 million, a decrease of 14% y
Buy Rating Affirmed for Organogenesis Holdings Amid Stable Product Pricing and Positive Market Dynamics
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) P/E Is On The Mark
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Organogenesis Holdings Inc. (NASDAQ:ORGO) as a stock to avoid entirely with
Organogenesis Holdings Full Year 2023 Earnings: Misses Expectations
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript
Why Organogenesis Holding Stock Plummeted by 18% Today
No Data